<DOC>
	<DOCNO>NCT00192725</DOCNO>
	<brief_summary>Serotonin ( 5-HT ) important mood regulation believe play major role pathophysiology major depression ( MD ) . Selective serotonin reuptake inhibitor ( SSRIs ) currently widely use drug treatment depression . Patients bipolar disorder ( BD ) treat depression SSRIs might develop mania , believe trigger antidepressant treatment . Rapid tryptophan depletion ( RTD ) show induce transient depressive symptom remit depressed patient treat SSRIs . In remitted manic patient treat lithium , RTD seem clinical effect . However , RTD study acutely manic patient could theoretically antimanic property . In double blind randomize placebo control study RTD use tool assess role 5-HT mania evaluate antimanic property potential use augmentation drug treatment acute mania .</brief_summary>
	<brief_title>Tryptophan Depletion Acute Mania</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Tryptophan</mesh_term>
	<criteria>Acute mania Ability provide write informed consent Mixed affective state Suicidal ideation Uncontrolled systemic illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>bipolar disorder</keyword>
	<keyword>acute mania</keyword>
	<keyword>tryptophan depletion</keyword>
	<keyword>placebo control add-on</keyword>
	<keyword>Bipolar disorder- manic type</keyword>
</DOC>